31/07/2026
๐ข ๐ฆ Horizon Europe funding opportunities for researchers working on infectious diseases and antimicrobial resistance โ flagged for cooperation with ASEAN institutions
The 2027 Horizon Europe Cluster 1 (Health) Work Programme includes 4๏ธโฃ calls that will support the development of novel antiviral therapeutics, monoclonal antibodies, and innovative antimicrobials to tackle pathogens with epidemic potential and drug-resistant infections.
While the calls open on 10 February 2027, now is the time to identify partners, discuss research ideas, and start building competitive international consortia.
๐๏ธ Opening: 10 February 2027
๐๏ธ Deadline: 13 April 2027
๐ฆ HORIZON-HLTH-2027-01-DISEASE-05: Development of novel small molecule antiviral therapeutics for pathogens with epidemic potential
๐ฆ HORIZON-HLTH-2027-01-DISEASE-06: Development of monoclonal antibodies to prevent and treat Flavivirus infections
๐ฆ HORIZON-HLTH-2027-01-DISEASE-07: Development of monoclonal antibodies to prevent and treat infections (filo-, nairo-, phenui-, picorna- and toga-viruses)
๐ฆ HORIZON-HLTH-2027-01-DISEASE-08: Development of innovative antimicrobials against resistant pathogens
๐ Find the full topic descriptions and call conditions in the Horizon Europe Work Programme 2027 โ Cluster 1Health: https://tinyurl.com/4m6r7h9m
๐ก Tip: On the EU Funding & Tenders Portal, simply enter the call ID (e.g. HORIZON-HLTH-2027-01-DISEASE-05) in the search bar, subscribe and receive call updates with your EU Login Account.
EU Science & Innovation